BIOBASE announced today that it is entering the Next Generation Sequencing (NGS) market with the launch of a new solution. Genome Trax™ enables researchers to identify genome variations of functional significance by mapping them to known elements such as gene regulatory sites and disease-linked mutations.
Researchers interpreting large numbers of sequence variants can now easily distinguish those variants that have biological importance. Genome Trax contains unique, manually-curated data from peer-reviewed literature, and is designed for seamless integration into existing NGS analysis workflows.
Dr. Frank Schacherer of BIOBASE GmbH said, “We have a powerful dataset that has been used for many high-profile human genome projects, such as the Craig Venter and the 1000 Genomes project.
With Genome Trax, we are making this data available in a form that is easy to use, and are confident it will greatly facilitate discovery in this important field of research.”
Source BIOBASE GmbH